Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 150.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 248.00
  • 52 Week Low: 150.00
  • Currency: UK Pounds
  • Shares Issued: 44.86m
  • Volume: 0
  • Market Cap: 67.29m

Ergomed Overview

Ergomed is in the pharma and biotech sector and is currently trading at 150.00p per share. In the last year Ergomed 's share price has ranged from 150.00p to 248.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -8.2% -3.6%
ROCE n/a  
Latest F'cast
P/E 35.7 n/a
PEG n/a n/a
Pr/Revenue 1.4 1.3
Pr/Book 1.9  
Latest F'cast
Revenue 21.4% 7.0%
PBT n/a n/a
EPS -38.2% n/a
DPS n/a n/a

Ergomed Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Ergomed Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 50.93 (1.83) (0.67)p n/a n/a n/a n/a 0.0%
31-Dec-19 59.53 1.95 5.31p 28.2 n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Ergomed Company Announcements

Board Changes 02-Oct-2018 14:47 RNS
Interim Results 19-Sep-2018 07:00 RNS
Notice of Interim Results 14-Sep-2018 07:00 RNS

Latest Ergomed Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Ergomed Market Data

Currency UK Pounds
Share Price 150.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 248.00
52 Week Low 150.00
Volume 0
Shares Issued 44.86m
Market Cap 67.29m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.73% below the market average13.73% below the market average13.73% below the market average13.73% below the market average13.73% below the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Price Trend
35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average
18.03% above the sector average18.03% above the sector average18.03% above the sector average18.03% above the sector average18.03% above the sector average
Income Not Available
Growth
33.25% above the market average33.25% above the market average33.25% above the market average33.25% above the market average33.25% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

Ergomed Key Personnel

Chair Peter George
CEO Stephen Stamp
COO Jan Petracek
CFO Stuart Jackson

Top of Page